Myrtille Prouté, MD, MSc

Profile

Medical public health specialist with 12+ years’ experience supporting international organisations, NGOs and government partners. Subject-matter expertise in epidemiology, surveillance and early warning, emergency preparedness and response, and health information systems. Work spans scoping and systematic reviews, programme evaluations, monitoring & evaluation frameworks, statistical analysis, and direct technical support — with a focus on translating complex data into actionable insights.

Work history

Since June 2019: Sigia — Montpellier, France

Founding partner of the international public health consultancy Sigia.

Since June 2026: External Expert — European Centre for Disease Prevention and Control (ECDC)

Since November 2025: Expert Evaluator — European Research Executive Agency (REA), Horizon Europe

Peer review and assessment of research and innovation proposals for the European Commission.

11/2017 – 05/2019: Freelance Public Health Consultant

  • Clinical coding (PMSI) optimisation missions in 10 French hospitals.
  • Methodological advice to the French National Institute for Demographic Studies (INED).

11/2012 – 10/2017: Medical Public Health Resident

Rotations at WHO, Médecins du Monde, AP-HP International, INED, INPES, COMEDE, Lundbeck and Paris-Dauphine University. See detailed experience below.

Consultancy projects, by area of expertise

Surveillance, early warning & health information systems

  • World Bank (2025). Scoping review on digital community-based surveillance.
  • WHO Kyrgyzstan (2024). Technical support to strengthen antimicrobial resistance coordination and surveillance.
  • WHO Europe (2023). Update and digitalisation of an assessment tool to strengthen in-country early warning and response (EWAR), usable in routine or emergency settings through a R-Shiny application.
  • WHO Kyrgyzstan (2023). Mapping of surveillance of zoonotic diseases to strengthen One Health collaboration.
  • BroadReach Group (2021). End-of-project evaluation of the Regional Action through Data programme.
  • WHO Eastern Mediterranean (2020). Scoping review on integrating data collection and data management across public health surveillance programmes.
  • WHO Kyrgyzstan (2020). Development of a COVID-19 monitoring dashboard and situation analysis of health information systems.
  • WHO Europe (2019). Development of an EWAR strategy and assessment tool; pilot testing in Georgia and Kyrgyzstan.

Emergency preparedness & response

  • ECDC (2026). Independent assessment of the setup and further operationalisation of the EU Health Task Force.
  • WHO Kyrgyzstan (2025). Support to the Ministry of Health to submit a proposal to the Pandemic Fund.
  • Robert Koch Institute (2024). Scoping review on strengthening community capacity for health emergency response.
  • WHO Headquarters (2024). Review of WHO monitoring and evaluation modalities in health emergency events.
  • WHO Kyrgyzstan (2021). Support to the implementation of a public health emergency operations centre and development of its integrated epidemiological platform.
  • WHO Headquarters (2020). Rapid scoping review on public health preparedness and response at mass gatherings.
  • WHO Headquarters (2020). Development and evaluation of a training course on the WHO Event Information Site.
  • WHO Headquarters (2020). Consolidation of risk-assessment data and development of an interactive visualisation dashboard for the WHO Strategic Tool for Assessing Risks (STAR).

Infectious disease outbreak response

  • Médecins Sans Frontières (2024). Evaluation of MSF’s intersectional response to the diphtheria outbreak in West Africa.
  • Médecins Sans Frontières (2023). Evaluation of MSF’s Lassa fever project in Ebonyi State, Nigeria.
  • WHO Africa (2021). Review of WHO involvement in Ebola virus disease outbreaks in the Democratic Republic of the Congo.

International Health Regulations & points of entry

  • WHO Kyrgyzstan (2023). Development of a risk-based approach to implement travel-related public health measures.
  • WHO Kyrgyzstan (2022). Assessment of IHR capacities at points of entry in the Kyrgyz Republic.
  • WHO South-East Asia (2021). Situation analysis of IHR capacities and challenges at ground crossings in Bangladesh, Bhutan, India and Nepal.
  • WHO Headquarters (2021). Analysis of core capacities at points of entry based on JEE and IHR reporting data.

Laboratory systems strengthening

  • WHO Headquarters (2024). Scoping review on the definition of public health laboratory services.
  • WHO Headquarters (2022). Scoping review on laboratory preparedness and response monitoring and evaluation.
  • WHO Headquarters (2022). Monitoring and evaluation framework for the Global Laboratory Leadership Programme.

Population health & access to care

  • Médecins du Monde (2025–2026). Statistical analysis and annual report on access to healthcare in France.
  • Monaco Department of Health Affairs (2025). Statistical analysis of health and ageing indicators.

Earlier experience (residency rotations, 2013–2017)

World Health Organization — Lyon, France (05/2017 – 10/2017)

  • Participation in the development of a toolbox for Argus implementation: an SMS and web application to support aggregated public health surveillance.
  • Participation in the organisation and facilitation of an international experts meeting to strengthen coordination of public health surveillance between points of entry and the national public health surveillance system.
  • Contribution to the review of the guide: “Coordination of public health surveillance between points of entry and the national public health surveillance system: advising principles ” and its implementation toolbox .

AP-HP International — Paris, France (11/2016 – 04/2017)

  • Institutional evaluation of the Brazzaville University Hospital, Republic of Congo, and contribution to the development of the hospital strategic project.
  • Contribution to the development of the hospital strategic project for the new Gafsa Regional Hospital, Tunisia.

INED and Program for HIV Prevention and Treatment (PHPT) / IRD174 — Chiang Mai, Thailand (11/2015 – 04/2016)

  • Conception and realisation of a respondent-driven sampling study to evaluate HCV prevention, screening and treatment among people who inject drugs in the Chiang Mai Province.
  • Follow-up of a cohort study on cervical cancer screening among HIV-positive women in Thailand.

Committee for the Health of Exiles (COMEDE) — Paris, France (05/2015 – 10/2015)

  • Qualitative study on the right to health of asylum seekers in Sweden, Germany, Italy and France.

Santé Publique France (formerly INPES) — Paris, France (05/2015 – 10/2015)

  • Secondary analysis of a KABP survey on sexual health in the French overseas departments.
  • Development of public-facing materials on HIV and vaccination.

Médecins du Monde — Paris, France (11/2013 – 05/2014)

Lundbeck — Paris, France (05/2013 – 10/2013)

  • Data analysis of a two-year cohort study on patients with depression in Europe.
  • Literature reviews, research protocol, abstract and poster drafting for several epidemiological studies.

LEGOS, Paris-Dauphine University — Paris, France (11/2012 – 04/2013)

Education

  • Medical degree with public health specialisation — University of Paris-Est Créteil (2017). MD thesis, bronze medal: “HCV prevention, screening and linkage to care in the Chiang Mai Province”.
  • Master of Science in Global Health — Maastricht University (2015). Focus: globalisation, health systems and policy.

Skills & languages

  • Methods: epidemiological analysis, qualitative research, survey design, systematic and scoping reviews, programme evaluation, monitoring & evaluation frameworks.
  • Tools: MAXQDA, R, RDSAT, LimeSurvey, Zotero, Rayyan.
  • Languages: French (native), English (fluent), Spanish (advanced), German (advanced).

Other activities

Member of the national chapter (2023–2024), Women in Global Health Spain

Member of the French Executive Committee (2014–2015) — General Secretary and member of the Executive Desk (2015–2016), Euronet MRPH (European public health residents’ network)

  • Management and animation of a network of public health medical residents’ associations.
  • Facilitation of internships abroad for European public health medical residents.
  • Training comparison of medical public health specialists in the member countries of the network.

Liaison officer to the International Federation of Medical Students’ Associations (IFMSA) for international public health projects (2008–2009), ANEMF (French National Association of Medical Students)

  • Organisation of a symposium on neglected tropical diseases for French medical students.
  • Conception and management of a university exchange research project on global health with France, Brazil and Peru.

Scientific publications

Sripan P, Prouté M, Ngo-Giang-Huong N, et al. Evaluation of cervical cancer screening strategies in women living with HIV in Thailand. Cancer Commun (Lond). 2025;45(5):525–528. doi.org/10.1002/cac2.70000

Prouté M, Le Coeur S, Tiv MH, et al. Risky injection practices and HCV awareness in Chiang Mai Province, Thailand: a respondent-driven sampling study of people who inject drugs. BMC Public Health. 2020;20:1450. doi.org/10.1186/s12889-020-09549-w

Bayen E, Laigle-Donadey F, Prouté M, et al. The multidimensional burden of informal caregivers in primary malignant brain tumor. Support Care Cancer. 2017;25(1):245–253. doi.org/10.1007/s00520-016-3397-6

Delory T, Ngo-Giang-Huong N, Rangdaeng S, …, Prouté M, et al. Human Papillomavirus infection and cervical lesions in HIV-infected women on antiretroviral treatment in Thailand. J Infect. 2017;74(5):501–511. doi.org/10.1016/j.jinf.2017.02.007

Bouscaillou J, Evanno J, Prouté M, et al. Prevalence and risk factors associated with HIV and tuberculosis in people who use drugs in Abidjan, Ivory Coast. Int J Drug Policy. 2016;30:116–123. doi.org/10.1016/j.drugpo.2016.02.010

Selected reports

Médecins du Monde (2025). Observatoire de l’accès aux droits et aux soins : Rapport 2025. In collaboration with Sigia.

Médecins Sans Frontières (2025). Evaluation of MSF intersectional response to the diphtheria outbreak in West Africa. Stockholm Evaluation Unit / Sigia.

Médecins Sans Frontières – OCB (2024). Evaluation of MSF’s Lassa Fever Project in Abakaliki, Nigeria. Stockholm Evaluation Unit / Sigia.

Oral communications

Prouté M, Le Coeur S, Tiv M, Dub T, Angkurawaranom C, Aramrattana A, Lallemant M. (2018) Risky injection practices and knowledge regarding HCV: a respondent-driven sampling study among people who inject drugs in the Chiang Mai Province, Thailand. Presented at AIDS 2018, Amsterdam, Netherlands.

Bouscaillou J, Massawe S, Voets A, Pont S, Prouté M, Luhmann N. (2014) Decrease of HIV prevalence over time among people who inject drugs (PWID) attending the harm reduction program of Médecins du Monde in Dar es Salaam, Tanzania. Presented at AIDS 2014, Melbourne, Australia.